Research is being conducted to evaluate a new solution using a vaccine to prevent an intestinal disease in poultry that costs ...

The poultry industry loses up to $6 billion annually due to necrotic enteritis, a preventable intestinal disease in poultry, including broiler chickens. An Arkansas Agricultural Experiment Station ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024PARIS, FRANCE, 18 ...

PBC treatments are available, even after the setback to Intercept Pharmaceuticals’ Ocaliva, but they are unable to reduce ...

PBC patients receiving linerixibat saw statistically significant improvement in cholestatic pruritus - or relentless itch.

French drugmaker Ipsen today announced the long-term efficacy and safety of patients treated with Bylvay (odevixibat) from ...

Ipsen announces Bylvay data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS: Paris, France Tuesday, November 19, 2024, 11:00 H ...

GSK announces positive results from GLISTEN phase III trial of linerixibat in adults with cholestatic pruritus (relentless itch) associated with PBC: London, UK Wednesday, Novembe ...

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS Back to video PARIS, FRANCE, 18 November, 2024 Ipsen (Euronext: IPN; ADR: ...